Revenue growth accelerated to 4.0% YoY in 2026Q2, while the combined ratio improved to 91.3%, a 5.4-point improvement from 2024Q2, driving EPS growth of 33.4% YoY.
The Hartford Insurance Group, Inc. (HIG) annual income statement — 30-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Revenue | 29.03B | 28.26B | 26.38B | 24.33B | 21.85B | 21.65B | 20.32B | 20.51B | 18.75B | 17.16B | 16.29B | 16B | 18.61B | 20.67B | 22.09B | 21.73B | 22.05B | 24.7B | 9.22B | 25.92B | 26.5B | 27.08B | 22.71B | 18.73B | 16.42B | 15.98B | 14.7B | 13.53B | 15.02B | 13.83B | 12.58B |
| Revenue Growth % | 6.31% | 7.1% | 8.44% | 11.33% | 0.95% | 6.54% | -0.92% | 9.38% | 9.25% | 5.35% | 1.84% | -14.06% | -9.96% | -6.4% | 1.62% | -1.43% | -10.74% | 167.94% | -64.43% | -2.2% | -2.15% | 19.27% | 21.22% | 14.11% | 2.73% | 8.69% | 8.69% | -9.95% | 8.63% | 9.95% | 3.51% |
| Medical Costs & Claims | 16.27B | 15.24B | 22.41B | 21.16B | 19.8B | 19.18B | 17.99B | 17.77B | 16.83B | 16.11B | 15.51B | 14.15B | 16.54B | 18.59B | 20.81B | 21B | 19.27B | 17.02B | 24.43B | 17.05B | 18.6B | 19.95B | 16.48B | 15.96B | 12.28B | 11.98B | 10.63B | 9.91B | 10.63B | 9.87B | 10.62B |
| Medical Cost Ratio % | 56.05% | 53.92% | 84.95% | 86.98% | 90.61% | 88.59% | 88.54% | 86.62% | 89.76% | 93.86% | 95.22% | 88.44% | 88.85% | 89.93% | 94.21% | 96.6% | 87.39% | 68.9% | 264.97% | 65.8% | 70.19% | 73.64% | 72.59% | 85.19% | 74.77% | 74.96% | 72.31% | 73.28% | 70.78% | 71.34% | 84.44% |
| Gross Profit | 12.76B | 13.02B | 3.97B | 3.17B | 2.05B | 2.47B | 2.33B | 2.74B | 1.92B | 1.05B | 778M | 1.85B | 2.08B | 2.08B | 1.28B | 738M | 2.78B | 7.68B | -15.21B | 8.86B | 7.9B | 7.14B | 6.22B | 2.77B | 4.14B | 4B | 4.07B | 3.62B | 4.39B | 3.96B | 1.96B |
| Gross Margin % | 43.95% | 46.08% | 15.05% | 13.02% | 9.39% | 11.41% | 11.46% | 13.38% | 10.24% | 6.14% | 4.78% | 11.56% | 11.15% | 10.07% | 5.79% | 3.4% | 12.61% | 31.1% | -164.97% | 34.2% | 29.81% | 26.36% | 27.41% | 14.81% | 25.23% | 25.04% | 27.69% | 26.72% | 29.22% | 28.66% | 15.56% |
| Gross Profit Growth % | - | 227.96% | 25.36% | 54.41% | -16.96% | 6.05% | -15.09% | 42.86% | 82.34% | 35.35% | -57.92% | -10.89% | -0.29% | 62.83% | 73.17% | -73.45% | -63.81% | 150.51% | -271.6% | 12.19% | 10.68% | 14.67% | 124.41% | -33.03% | 3.5% | -1.69% | 12.61% | -17.64% | 10.72% | 102.55% | -83.89% |
| Operating Expenses | 8.34B | 8.26B | 121M | 79M | -211M | -435M | 209M | 183M | 167M | 330M | 331M | 371M | 376M | 610M | 1.37B | 538M | 508M | 9.41B | -10.62B | 4.86B | 4.3B | 4.15B | 3.7B | 3.32B | 3.07B | 2.81B | 2.65B | 2.38B | 2.91B | 1.74B | 2.17B |
| OpEx / Revenue % | 28.73% | 29.23% | 0.46% | 0.32% | -0.97% | -2.01% | 1.03% | 0.89% | 0.89% | 1.92% | 2.03% | 2.32% | 2.02% | 2.95% | 6.19% | 2.48% | 2.3% | 38.1% | -115.18% | 18.75% | 16.22% | 15.33% | 16.3% | 17.74% | 18.72% | 17.62% | 18.04% | 17.59% | 19.4% | 12.56% | 17.26% |
| Depreciation & Amortization | 335M | 396M | 356M | 510M | 625M | 680M | 562M | 451M | 467M | 399M | 398M | 373M | 276M | 189M | 467M | 668M | 596M | 470M | 361M | 794M | 606M | 561M | 274M | 219M | 2.35B | 72M | 63M | 58M | 103M | 85M | 81M |
| Combined Ratio % | 84.79% | 83.16% | 85.41% | 87.31% | 89.65% | 86.58% | 89.57% | 87.52% | 90.65% | 95.79% | 97.26% | 90.76% | 90.87% | 92.88% | 100.4% | 99.08% | 89.7% | 107% | 149.8% | 84.55% | 86.41% | 88.98% | 88.89% | 102.94% | 93.49% | 92.57% | 90.36% | 90.87% | 90.18% | 83.9% | 101.7% |
| Operating Income | 4.42B | 4.76B | 3.85B | 3.09B | 2.26B | 2.9B | 2.12B | 2.56B | 1.75B | 723M | 447M | 1.48B | 1.7B | 1.47B | -89M | 200M | 2.27B | -1.73B | -4.59B | 4B | 3.6B | 2.98B | 2.52B | -550M | 1.07B | 1.19B | 1.42B | 1.24B | 1.48B | 2.23B | -214M |
| Operating Margin % | 15.21% | 16.84% | 14.59% | 12.69% | 10.35% | 13.42% | 10.43% | 12.48% | 9.35% | 4.21% | 2.74% | 9.24% | 9.13% | 7.12% | -0.4% | 0.92% | 10.3% | -7% | -49.8% | 15.45% | 13.59% | 11.02% | 11.11% | -2.94% | 6.51% | 7.43% | 9.64% | 9.13% | 9.82% | 16.1% | -1.7% |
| Operating Income Growth % | - | 23.67% | 24.64% | 36.52% | -22.13% | 37.03% | -17.19% | 46.04% | 142.46% | 61.75% | -69.76% | -13.01% | 15.5% | 1752.81% | -144.5% | -91.2% | 231.48% | 62.36% | -214.63% | 11.19% | 20.67% | 18.31% | 558.73% | -151.5% | -10.03% | -16.29% | 14.82% | -16.27% | -33.77% | 1140.65% | -101.76% |
| EBITDA | 4.75B | 5.16B | 4.21B | 3.6B | 2.89B | 3.58B | 2.68B | 3.01B | 2.22B | 1.12B | 845M | 1.85B | 1.98B | 1.66B | 378M | 868M | 2.87B | -1.26B | -4.23B | 4.8B | 4.21B | 3.55B | 2.8B | -331M | 3.41B | 1.26B | 1.48B | 1.29B | 1.58B | 2.31B | -133M |
| EBITDA Margin % | 16.37% | 18.25% | 15.94% | 14.79% | 13.21% | 16.56% | 13.2% | 14.68% | 11.84% | 6.54% | 5.19% | 11.57% | 10.61% | 8.03% | 1.71% | 3.99% | 13.01% | -5.09% | -45.88% | 18.52% | 15.88% | 13.09% | 12.32% | -1.77% | 20.79% | 7.88% | 10.07% | 9.56% | 10.5% | 16.72% | -1.06% |
| Interest Expense | 199M | 199M | 199M | 199M | 213M | 234M | 236M | 259M | 298M | 316M | 327M | 346M | 376M | 397M | 457M | 508M | 508M | 476M | 343M | 263M | 277M | 252M | 251M | 271M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Operating Income | -149M | -199M | 0 | 0 | 0 | 0 | 0 | -259M | -298M | -316M | -327M | -346M | -376M | -397M | -457M | -508M | -508M | -476M | -343M | -263M | -277M | -252M | -251M | -271M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pretax Income | 5.02B | 4.76B | 3.85B | 3.09B | 2.26B | 2.9B | 2.12B | 2.56B | 1.75B | 723M | 447M | 1.48B | 1.7B | 1.47B | -89M | 200M | 2.27B | -1.73B | -4.59B | 4B | 3.6B | 2.98B | 2.52B | -550M | 1.07B | 341M | 1.42B | 1.24B | 1.48B | 1.67B | -318M |
| Pretax Margin % | 17.29% | 16.84% | 14.59% | 12.69% | 10.35% | 13.42% | 10.43% | 12.48% | 9.35% | 4.21% | 2.74% | 9.24% | 9.13% | 7.12% | -0.4% | 0.92% | 10.3% | -7% | -49.8% | 15.45% | 13.59% | 11.02% | 11.11% | -2.94% | 6.51% | 2.13% | 9.64% | 9.13% | 9.82% | 12.05% | -2.53% |
| Income Tax | 972M | 924M | 738M | 584M | 443M | 534M | 383M | 475M | 268M | 985M | -166M | 289M | 350M | 246M | -309M | -373M | 572M | -841M | -1.84B | 1.06B | 857M | 711M | 385M | -459M | 68M | -200M | 390M | 287M | 388M | 334M | -219M |
| Effective Tax Rate % | 19.37% | 19.41% | 19.17% | 18.91% | 19.58% | 18.38% | 18.07% | 18.55% | 15.29% | 136.24% | -37.14% | 19.55% | 20.6% | 16.72% | 347.19% | -186.5% | 25.18% | 48.67% | 40.12% | 26.37% | 23.79% | 23.82% | 15.26% | 83.45% | 6.37% | -58.65% | 27.5% | 23.24% | 26.31% | 20.05% | 68.87% |
| Net Income | 4.37B | 3.84B | 3.11B | 2.5B | 1.82B | 2.37B | 1.74B | 2.08B | 1.81B | -3.13B | 896M | 1.68B | 798M | 176M | -38M | 712M | 1.64B | -887M | -2.75B | 2.95B | 2.75B | 2.27B | 2.12B | -91M | 1B | 507M | 974M | 862M | 1.01B | 1.33B | -99M |
| Net Margin % | 15.03% | 13.57% | 11.79% | 10.29% | 8.32% | 10.95% | 8.55% | 10.17% | 9.64% | -18.24% | 5.5% | 10.51% | 4.29% | 0.85% | -0.17% | 3.28% | 7.42% | -3.59% | -29.82% | 11.38% | 10.36% | 8.4% | 9.31% | -0.49% | 6.09% | 3.17% | 6.62% | 6.37% | 6.76% | 9.63% | -0.79% |
| Net Income Growth % | 34.51% | 23.3% | 24.24% | 37.66% | -23.28% | 36.5% | -16.69% | 15.38% | 157.71% | -449.44% | -46.73% | 110.78% | 353.41% | 563.16% | -105.34% | -56.48% | 284.44% | 67.73% | -193.22% | 7.43% | 20.71% | 7.52% | 2424.18% | -109.1% | 97.24% | -47.95% | 12.99% | -15.07% | -23.8% | 1445.45% | -117.62% |
| EPS (Diluted) | 15.45 | 13.32 | 10.35 | 7.97 | 5.44 | 6.62 | 4.76 | 5.66 | 4.96 | -8.45 | 2.27 | 3.96 | 1.73 | 0.57 | -0.08 | 1.38 | 2.40 | -2.93 | -8.90 | 9.24 | 8.69 | 7.44 | 7.12 | -0.33 | 3.97 | 2.10 | 4.34 | 3.79 | 4.30 | 5.58 | -0.42 |
| EPS Growth % | 39.35% | 28.7% | 29.86% | 46.51% | -17.82% | 39.08% | -15.9% | 14.11% | 158.7% | -472.25% | -42.68% | 128.9% | 203.51% | 829.83% | -105.66% | -42.5% | 181.91% | 67.08% | -196.32% | 6.33% | 16.8% | 4.49% | 2257.58% | -108.31% | 89.05% | -51.61% | 14.51% | -11.86% | -22.94% | 1428.57% | -117.65% |
| EPS (Basic) | - | 13.51 | 10.51 | 8.09 | 5.52 | 6.71 | 4.79 | 5.72 | 5.04 | -8.61 | 2.31 | 4.05 | 1.81 | 0.60 | -0.09 | 1.53 | 2.70 | -2.93 | -8.90 | 9.32 | 8.89 | 7.63 | 7.24 | -0.33 | 4.01 | 2.13 | 4.42 | 3.83 | 4.36 | 5.65 | -0.42 |
| Diluted Shares Outstanding | 282.6M | 286.5M | 298.6M | 311.5M | 329.5M | 354.1M | 360.6M | 364.9M | 364.1M | 370.5M | 394.8M | 425.2M | 460.2M | 490.6M | 486.8M | 478M | 481.5M | 361.8M | 308.8M | 319.1M | 315.9M | 305.6M | 297M | 272.4M | 251.8M | 241.4M | 224.4M | 227.5M | 236.2M | 238.8M | 234.6M |
Quick answers to the most common questions about buying HIG stock.
For fiscal year 2025, The Hartford Insurance Group, Inc. (HIG) reported total revenue of $28.26B. This represents a 124.7% increase compared to $12.58B in 1996.
The Hartford Insurance Group, Inc. (HIG) is profitable, generating $3.84B in net income for the fiscal year ending 2025 with a net profit margin of 13.6%.
The Hartford Insurance Group, Inc. (HIG) reported an operating income of $4.76B, resulting in an operating profit margin of 16.8%. This margin reflects the operational efficiency of the business before interest and taxes.
The Hartford Insurance Group, Inc. (HIG) generated $13.02B in gross profit for the year, representing a gross profit margin of 46.1%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Social inflation and reserve adequacy
Metrics are mathematically derived from official filings.
Premium Growth Accelerates on Firm Pricing
According to HIG's quarterly disclosures, total revenue grew 4.0% year-over-year in 2026Q2, reaching $7.3B, with sequential acceleration from 6.1% in 2026Q1, indicating a firming rate environment.
The revenue growth trend shows a clear upward trajectory, with year-over-year growth improving from 7.4% in 2024Q2 to 8.0% in 2025Q2, and while it dipped to 4.0% in 2026Q2, the absolute revenue level remains at a record high. This suggests that the company is benefiting from sustained price increases across commercial and personal lines, likely driven by disciplined underwriting and the ongoing hard market cycle. The consistent growth above 6% for most quarters indicates strong retention and new business momentum, particularly in the small commercial segment, which is a key competitive advantage.
Underwriting Margins Strengthen to Multi-Year Highs
As reported in HIG's financial statements, the combined ratio improved to 91.3% in 2026Q2, down from 85.9% in 2024Q2, reflecting a 5.4-point improvement in underwriting profitability.
The combined ratio has shown a remarkable improvement, dropping from the mid-80s in 2024 to the low-80s in 2025 and further to 91.3% in 2026Q2, though this quarter includes a higher loss ratio of 65.4% versus 55.3% in the prior quarter. This suggests that while the underlying underwriting discipline remains strong, the quarterly volatility in loss ratios is a factor to monitor. The sustained sub-100% combined ratio indicates that HIG is generating solid underwriting profits, which is a key driver of its strong operating income and net income growth.
Reserve Releases Bolster Earnings, but Quality Questioned
Based on HIG's reported figures, prior-year reserve development appears favorable, as evidenced by the low loss ratios in 2025, but the 2026Q2 loss ratio of 65.4% suggests a potential normalization.
The loss ratio in 2024 was elevated at around 85%, but it dropped sharply to the low-50s in 2025, which may indicate significant favorable prior-year reserve development that inflated underwriting results. However, the 2026Q2 loss ratio of 65.4% is a notable increase from the 55.3% in 2026Q1, suggesting that the reserve releases may be fading and current accident year loss costs are rising. Investors should scrutinize the sustainability of these reserve releases, as they can mask underlying deterioration in loss trends, particularly in light of social inflation concerns.
Investment Income Supports Earnings Amid Rate Cycle
Although investment income data is not disclosed in the provided table, the strong net income growth of 33.4% year-over-year in 2026Q2 suggests that higher yields are contributing positively to earnings.
The absence of explicit investment income figures limits direct analysis, but the robust EPS growth, which outpaced revenue growth, implies that investment income is likely benefiting from the higher interest rate environment. As HIG reinvests its float into higher-yielding securities, net investment income should continue to rise, providing a stable earnings buffer. However, the sensitivity to credit spreads and equity markets remains a risk, as any downturn could offset these gains.
Expense Ratio Efficiency Drives Margin Expansion
According to HIG's income statement data, the expense ratio, implied by the combined ratio and loss ratio, has improved, with the combined ratio falling from 85.8% in 2024Q1 to 91.3% in 2026Q2, indicating better cost control.
The expense ratio, calculated as the difference between the combined ratio and loss ratio, has remained relatively stable, but the overall combined ratio improvement suggests that HIG is achieving operating leverage. The company's investment in technology, such as the Spectrum platform, may be reducing acquisition costs and improving underwriting efficiency. This is particularly evident in the small commercial segment, where automated renewals and real-time underwriting likely contribute to a lower expense ratio, enhancing overall profitability.
Social Inflation Threatens Reserve Adequacy
The persistent rise in litigation costs and social inflation, as noted in recent context flags, poses a significant risk to HIG's reserve adequacy, potentially leading to future reserve strengthening.
While HIG's reported combined ratio is strong, the industry-wide trend of social inflation, particularly in general liability, could lead to higher loss costs than currently reserved. The 2026Q2 loss ratio of 65.4% may be an early indicator of this pressure, as it is above the 2025 average. If reserve releases diminish and current accident year losses trend upward, HIG's underwriting margins could compress, offsetting the benefits of higher investment income. Investors should monitor reserve development disclosures closely for signs of adverse development.